Sweet Syndrome Following SARS-CoV2 Vaccination

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, Francesca Montefusco, Stefano Senatore, Daniela Massi, Emiliano Antiga
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	Sweet’s syndrome mRNA vaccines neutrophilic dermatoses adverse event Medicine R
Acceso en línea:	https://doaj.org/article/382109afaae34e4cb9080019238e003d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:382109afaae34e4cb9080019238e003d
record_format	dspace
spelling	oai:doaj.org-article:382109afaae34e4cb9080019238e003d2021-11-25T19:10:04ZSweet Syndrome Following SARS-CoV2 Vaccination10.3390/vaccines91112122076-393Xhttps://doaj.org/article/382109afaae34e4cb9080019238e003d2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1212https://doaj.org/toc/2076-393XVaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet’s syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet’s syndrome in this case.Maria Efenesia BaffaRoberto MaglieNeri GiovannozziFrancesca MontefuscoStefano SenatoreDaniela MassiEmiliano AntigaMDPI AGarticleSweet’s syndromemRNA vaccinesneutrophilic dermatosesadverse eventMedicineRENVaccines, Vol 9, Iss 1212, p 1212 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Sweet’s syndrome mRNA vaccines neutrophilic dermatoses adverse event Medicine R
spellingShingle	Sweet’s syndrome mRNA vaccines neutrophilic dermatoses adverse event Medicine R Maria Efenesia Baffa Roberto Maglie Neri Giovannozzi Francesca Montefusco Stefano Senatore Daniela Massi Emiliano Antiga Sweet Syndrome Following SARS-CoV2 Vaccination
description	Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet’s syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet’s syndrome in this case.
format	article
author	Maria Efenesia Baffa Roberto Maglie Neri Giovannozzi Francesca Montefusco Stefano Senatore Daniela Massi Emiliano Antiga
author_facet	Maria Efenesia Baffa Roberto Maglie Neri Giovannozzi Francesca Montefusco Stefano Senatore Daniela Massi Emiliano Antiga
author_sort	Maria Efenesia Baffa
title	Sweet Syndrome Following SARS-CoV2 Vaccination
title_short	Sweet Syndrome Following SARS-CoV2 Vaccination
title_full	Sweet Syndrome Following SARS-CoV2 Vaccination
title_fullStr	Sweet Syndrome Following SARS-CoV2 Vaccination
title_full_unstemmed	Sweet Syndrome Following SARS-CoV2 Vaccination
title_sort	sweet syndrome following sars-cov2 vaccination
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/382109afaae34e4cb9080019238e003d
work_keys_str_mv	AT mariaefenesiabaffa sweetsyndromefollowingsarscov2vaccination AT robertomaglie sweetsyndromefollowingsarscov2vaccination AT nerigiovannozzi sweetsyndromefollowingsarscov2vaccination AT francescamontefusco sweetsyndromefollowingsarscov2vaccination AT stefanosenatore sweetsyndromefollowingsarscov2vaccination AT danielamassi sweetsyndromefollowingsarscov2vaccination AT emilianoantiga sweetsyndromefollowingsarscov2vaccination
_version_	1718410207952896000

Sweet Syndrome Following SARS-CoV2 Vaccination

Ejemplares similares